ID: ALA2441555

Max Phase: Preclinical

Molecular Formula: C20H34ClNO2

Molecular Weight: 319.49

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCCCCCCCc1ccc(CO[C@H]2CN[C@H](CO)C2)cc1.Cl

Standard InChI:  InChI=1S/C20H33NO2.ClH/c1-2-3-4-5-6-7-8-17-9-11-18(12-10-17)16-23-20-13-19(15-22)21-14-20;/h9-12,19-22H,2-8,13-16H2,1H3;1H/t19-,20+;/m0./s1

Standard InChI Key:  ICGWLOCGXMULOL-CMXBXVFLSA-N

Associated Targets(Human)

NALM-6 592 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

DU-145 51482 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

PC-3 62116 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

CCRF-CEM 65223 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

BV-173 173 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

FL5.12 351 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 319.49Molecular Weight (Monoisotopic): 319.2511AlogP: 3.83#Rotatable Bonds: 11
Polar Surface Area: 41.49Molecular Species: BASEHBA: 3HBD: 2
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.97CX LogP: 4.43CX LogD: 1.94
Aromatic Rings: 1Heavy Atoms: 23QED Weighted: 0.61Np Likeness Score: 0.79

References

1. Fransson R, McCracken AN, Chen B, McMonigle RJ, Edinger AL, Hanessian S..  (2013)  Design, Synthesis, and Anti-leukemic Activity of Stereochemically Defined Constrained Analogs of FTY720 (Gilenya).,  (10): [PMID:24273632] [10.1021/ml4002425]
2. Perryman MS, Tessier J, Wiher T, O'Donoghue H, McCracken AN, Kim SM, Nguyen DG, Simitian GS, Viana M, Rafelski S, Edinger AL, Hanessian S..  (2016)  Effects of stereochemistry, saturation, and hydrocarbon chain length on the ability of synthetic constrained azacyclic sphingolipids to trigger nutrient transporter down-regulation, vacuolation, and cell death.,  24  (18): [PMID:27475534] [10.1016/j.bmc.2016.07.038]

Source